| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.0092 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0059 | 1 |